Standing Out in the Crowd - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Standing Out in the Crowd
Supplier differentiation is increasingly important in the highly competitive arena of pharmaceutical outsourcing.


Pharmaceutical Technology
Volume 35, pp. s6

Amidst these conditions, we explore how contract-service providers can achieve competitive advantage by looking at the drivers that influence customers' perceptions of contract-service providers overall and in certain segments (see "Customer Drivers Influencing Supplier Differentiation").

As the level and complexity of outsourcing increases, bio/pharmaceutical companies speak about how project management is a valued competency of a contract-service provider not only in meeting its obligations, but also in working with other service providers. To illustrate, we offer a case study of a cross-functional supplier integration model (see "Achieving Cross-Functional Supplier Integration: A Case-Study Analysis").

Part of the task in developing a sustainable competitive advantage is to understand not only what customers value now, but what they will in the future. As bio/pharmaceutical companies begin to adapt quality by design (QbD) in their drug-development and manufacturing efforts, will competency in QbD become equally important for contract-service providers? We gain perspectives from both sides of this issue. Senior executives from Pfizer offer insight on the company's experience with QbD (see "A Pharma Manufacturer’s View of Quality by Design"), and an industry roundtable of technology and contract-service providers share their views on the influence of QbD on the outsourced relationship (see "Evaluating QbD's Impact on the Outsourced Relationship").

Also in this issue, Avantor shares its experience in a pilot of the shared audit process of Rx–360, the international pharmaceutical supply-chain consortium (see "Rx-360 Completes Pilot Audit of Manufacturing Facility: An Industry Case Study from Avantor"). We also share best practices in collaborative planning (see "Outsourced Manufacturing Operations") and technology transfer (see "Managing Technology Transfer: Developing a Complete CMC Package for an In-Licensed Product").

Patricia Van Anrum is a senior editor of Pharmaceutical Technology,
and a co-editor of this special issue.

References

1. M.E. Porter, Competitive Advantage: Creating and Sustaining Superior Performance (Free Press, 1st ed., New York, 1985).

2. M.E. Porter, Competitive Strategy: Techniques for Analyzing Industries and Competitors (Free Press, 1st ed., New York, 1980).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What is the single greatest threat to maintaining manufacturing processes at your facility?
Quality issues
Facility/environment problems
Process development problems
Production equipment downtime
Raw material supply problems
Regulatory restrictions
Business decisions to limit production
Quality issues
67%
Facility/environment problems
0%
Process development problems
0%
Production equipment downtime
0%
Raw material supply problems
33%
Regulatory restrictions
0%
Business decisions to limit production
0%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Patent Settlements Become More Risky
Praise and Perils for Biotechnology Patent Policy
Risk-Mitigation Strategies in Drug Manufacturing for Emerging Markets
Quality Focus: Ensuring Raw Material Transparency
Advertising of Prescription Drugs  Keeping it Honest and Balanced
Source: Pharmaceutical Technology,
Click here